Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Pharma industry appointments

Destiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams.

- PMLiVE

90TEN celebrates double win for HIV campaign at Communiqué 2018

Agency wins two awards for bold My Journey: Flight HIV101 campaign

- PMLiVE

Sanofi’s rare blood disorder drug Cablivi set for European approval

Rare disease drug among notable CHMP recommendations

- PMLiVE

NHS bracing for ‘no deal’ Brexit impact, including medicines

Simon Stevens says plans well advanced for shock to supply chain

- PMLiVE

Incisive Health and 90TEN take home Integrated Communications awards

The agencies were victorious at Communiqué 2018

- PMLiVE

Porterhouse Medical launches new website showcasing the latest exciting developments within the group.

Porterhouse Medical Group is thrilled to launch a new website (www.porterhousemedical.com) highlighting the expansion of the group over the past 6 months, developments that have seen the addition of a suite...

Porterhouse Medical Group

- PMLiVE

Mylan sees the UK paving the way for an insulin game changer

As biosimilars surge into the insulin market, governments  are urged to seize ‘the opportunity of the century’

- PMLiVE

CAR-Ts Kymriah and Yescarta step closer to approval in Europe

Final European approval around the corner - but reimbursement and specialist centres among outstanding issues

- PMLiVE

Kate Pogson is named Communiqué’s Healthcare Communications Leader 2018

Judges say Pogson is a "clear leader of the future"

- PMLiVE

UniQure’s starts pivotal haemophilia B gene therapy trial

The treatment could relieve haemophilia B patients from factor IX replacement drugs

- PMLiVE

Amazon shocks pharmacy sector with PillPack deal

Shares in big US pharmacy chains slide on news

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links